ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
27.04 USD
+0.28 (+1.05%)
27.04 USD
0 (0%)
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 187 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ENOV while its profitability can be described as average. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
ENOV had positive earnings in the past year.
ENOV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
ENOV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -30.84%, ENOV perfoms like the industry average, outperforming 43.32% of the companies in the same industry.
Looking at the Return On Equity, with a value of -67.66%, ENOV is in line with its industry, outperforming 45.99% of the companies in the same industry.
ENOV's Return On Invested Capital of 0.12% is fine compared to the rest of the industry. ENOV outperforms 65.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 0.25%, ENOV is doing good in the industry, outperforming 65.24% of the companies in the same industry.
ENOV's Operating Margin has declined in the last couple of years.
The Gross Margin of ENOV (57.19%) is comparable to the rest of the industry.
ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
Compared to 1 year ago, ENOV has more shares outstanding
The number of shares outstanding for ENOV has been increased compared to 5 years ago.
The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.78, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
ENOV has a Altman-Z score (0.78) which is comparable to the rest of the industry.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
ENOV has a better Debt to FCF ratio (59.72) than 67.91% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
ENOV has a worse Debt to Equity ratio (0.66) than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.78 |
ROIC/WACC0.02
WACC7.25%
2.3 Liquidity
ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
ENOV has a Current ratio (2.22) which is comparable to the rest of the industry.
ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
ENOV has a worse Quick ratio (1.16) than 71.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.14% over the past year.
ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
ENOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.57%.
The Revenue has been decreasing by -8.73% on average over the past years.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
Based on estimates for the next years, ENOV will show a very strong growth in Earnings Per Share. The EPS will grow by 23.19% on average per year.
ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.87% yearly.
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.12, which indicates a very decent valuation of ENOV.
Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 96.26% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.28. ENOV is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.70 indicates a rather cheap valuation of ENOV.
ENOV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 97.86% of the companies in the same industry.
ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.12 | ||
| Fwd PE | 7.7 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaper than 91.98% of the companies in the same industry.
71.66% of the companies in the same industry are more expensive than ENOV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 67.93 | ||
| EV/EBITDA | 9.6 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y11.4%
EPS Next 3Y11.38%
5. Dividend
5.1 Amount
No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.04
+0.28 (+1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.5%
Inst Owner Change-2.39%
Ins Owners1.2%
Ins Owner Change0.83%
Market Cap1.55B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target49.07 (81.47%)
Short Float %13.78%
Short Ratio10.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-7.03%
PT rev (3m)-11.45%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)1.75%
EPS NY rev (3m)1.73%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.12 | ||
| Fwd PE | 7.7 | ||
| P/S | 0.69 | ||
| P/FCF | 67.93 | ||
| P/OCF | 7.12 | ||
| P/B | 0.77 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.6 |
EPS(TTM)3.33
EY12.32%
EPS(NY)3.51
Fwd EY12.99%
FCF(TTM)0.4
FCFY1.47%
OCF(TTM)3.8
OCFY14.04%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.56
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.78 |
F-Score4
WACC7.25%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.5%
EBIT Next 3Y28.12%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.56% in the next year.